Total trials
116
Active
18
Phase 3
16
Total enrollment
56,646
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Emtriva | — | — | — | — | — | 1 |
Next readouts
- 2026-03-31
Top conditions
- Depression18
- Suicide8
- Obsessive-Compulsive Disorder6
- Major Depressive Disorder6
- HIV6
- Suicide and Self-harm5
- Suicidal Ideation5
- Suicide, Attempted4
Frequently asked questions about Butler Hospital
- How many clinical trials does Butler Hospital have on ClinicalTrials.gov?
- Butler Hospital is listed as the lead sponsor on 116 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Butler Hospital's trials are in Phase 3?
- 16 of Butler Hospital's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Butler Hospital focus on?
- Butler Hospital's most-studied conditions on ClinicalTrials.gov are Depression, Suicide, Obsessive-Compulsive Disorder, Major Depressive Disorder, HIV.
- When are Butler Hospital's next clinical trial readouts?
- Butler Hospital has 1 upcoming primary-completion readout tracked here; the soonest is “Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD”, expected around 2026-03-31.